Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia

NCT01331590 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

DRUG: G-CSF
DRUG: Ifosfamide
DRUG: Etoposide
DRUG: Dexamethasone
DRUG: Mesna

Sponsor

Washington University School of Medicine